Generics

Apr 18, 2014
Actavis on Friday announced that it has entered into agreements with Akorn...
DUBLIN — Actavis on Friday announced that it has entered into...
more
Apr 18, 2014
Evidence-based interventions at the local and national levels provide...
ATLANTA — Evidence-based interventions at the local and national...
more
Apr 17, 2014
Rates of five major diabetes-related complications have declined...
ATLANTA — Rates of five major diabetes-related complications have...
more
Apr 17, 2014
Akorn on Thursday announced that it has completed its previously announced...
LAKE FOREST, Ill. — Akorn on Thursday announced that it has...
more
Apr 17, 2014
Mylan announced the launch of Xulane (norelgestromin/ethinyl estradiol...
PITTSBURGH — Mylan announced the launch of Xulane (norelgestromin/...
more
Apr 17, 2014
Teva Pharmaceutical announced that its U.S. subsidiary has entered into a...
JERUSALEM — Teva Pharmaceutical on Thursday announced that its U.S....
more
Apr 16, 2014
Cases of diabetes and pre-diabetes in the United States have nearly...
BALTIMORE — Cases of diabetes and pre-diabetes in the United States...
more

EXCLUSIVE REPORT

RxImpact 2014
Timed with NACDS RxImpact Day on Capitol Hill, DSN looks at how community pharmacy fills gaps in access and affordability for patients and payers. Click here to download the exclusive report.

SPECIAL REPORT

From 2012 to 2017, global spending on medicines will increase from $205 billion...

PHARMACY AFFAIRS

It has been estimated that specialty accounts for about 20% of the total drug...
DSN recently sat down with Kerr Drug's Tony Civello to talk about how, like...